Trials / Completed
CompletedNCT04107207
Evaluating the Effects of Kombucha as a Hyperglycemic Therapeutic Agent Within Diabetic Human Subjects
Pilot Study to Evaluate Effects of Kombucha as a Hyperglycemic Therapeutic Agent Within Diabetic Human Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Georgetown University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study's primary objective is to determine the ability of Kombucha to impact blood sugar levels in patients with diabetes mellitus type II. The secondary objective is to determine the ability of Kombucha to impact blood pressure, and quality of life measures as measured by uniform questionnaire that includes: gut health, colds, infections, headaches, sleep, anxiety (GAD2), depression (PHQ2), skin health.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Ginger Kombucha | Craft Ginger Kombucha, a fermented black tea |
| DIETARY_SUPPLEMENT | Ginger Water | Placebo |
Timeline
- Start date
- 2019-11-11
- Primary completion
- 2020-05-20
- Completion
- 2020-07-01
- First posted
- 2019-09-27
- Last updated
- 2020-07-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04107207. Inclusion in this directory is not an endorsement.